The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils.
about
Beta conformation of polyglutamine track revealed by a crystal structure of Huntingtin N-terminal region with insertion of three histidine residuesAtomic structure and hierarchical assembly of a cross- amyloid fibrilStructure and Topology of the Huntingtin 1–17 Membrane Anchor by a Combined Solution and Solid-State NMR ApproachMechanistic insight into the relationship between N-terminal acetylation of α-synuclein and fibril formation rates by NMR and fluorescenceUnlike twins: an NMR comparison of two α-synuclein polymorphs featuring different toxicityScalable production in human cells and biochemical characterization of full-length normal and mutant huntingtinGlutamine and Asparagine Side Chain Hyperconjugation-Induced Structurally Sensitive Vibrations.Super-resolution fluorescence of huntingtin reveals growth of globular species into short fibers and coexistence of distinct aggregatesElucidation of the Aggregation Pathways of Helix-Turn-Helix Peptides: Stabilization at the Turn Region Is Critical for Fibril Formation.Free-Energy Landscape of the Amino-Terminal Fragment of Huntingtin in Aqueous SolutionCataract-associated P23T γD-crystallin retains a native-like fold in amorphous-looking aggregates formed at physiological pH.Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine coreMonomeric, oligomeric and polymeric proteins in huntington disease and other diseases of polyglutamine expansionInvestigating the structural impact of the glutamine repeat in huntingtin assembly.Resolving the paradox for protein aggregation diseases: NMR structure and dynamics of the membrane-embedded P56S-MSP causing ALS imply a common mechanism for aggregation-prone proteins to attack membranesPolyglutamine amyloid core boundaries and flanking domain dynamics in huntingtin fragment fibrils determined by solid-state nuclear magnetic resonance.Molecular interaction between the chaperone Hsc70 and the N-terminal flank of huntingtin exon 1 modulates aggregationAmyloid-like fibrils from a domain-swapping protein feature a parallel, in-register conformation without native-like interactions.Kinetically competing huntingtin aggregation pathways control amyloid polymorphism and propertiesThe emerging role of the first 17 amino acids of huntingtin in Huntington's diseaseHuntingtin N-Terminal Monomeric and Multimeric Structures Destabilized by Covalent Modification of Heteroatomic Residues.Fibrillar structure and charge determine the interaction of polyglutamine protein aggregates with the cell surface.Structural features and domain organization of huntingtin fibrils.CAMELOT: A machine learning approach for coarse-grained simulations of aggregation of block-copolymeric protein sequences.α-Synuclein and huntingtin exon 1 amyloid fibrils bind laterally to the cellular membrane.Huntingtin exon 1 fibrils feature an interdigitated β-hairpin-based polyglutamine coreSlow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments.Solid-State Nuclear Magnetic Resonance on the Static and Dynamic Domains of Huntingtin Exon-1 Fibrils.Efficient resonance assignment of proteins in MAS NMR by simultaneous intra- and inter-residue 3D correlation spectroscopy.Levels of supramolecular chirality of polyglutamine aggregates revealed by vibrational circular dichroism.Acetylation within the First 17 Residues of Huntingtin Exon 1 Alters Aggregation and Lipid Binding.Nanoscale studies link amyloid maturity with polyglutamine diseases onset.Identification and Structural Characterization of the N-terminal Amyloid Core of Orb2 isoform A.Investigating Mutations to Reduce Huntingtin Aggregation by Increasing Htt-N-Terminal Stability and Weakening Interactions with PolyQ Domain.SUMO-2 and PIAS1 modulate insoluble mutant huntingtin protein accumulation.Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch.Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.A serendipitous survey of prediction algorithms for amyloidogenicity.Advances in huntington disease drug discovery: novel approaches to model disease phenotypes.Polyglutamine Aggregation in Huntington Disease: Does Structure Determine Toxicity?
P2860
Q27676093-74132AD9-867F-4A89-8E4E-1F56C797EDF9Q27676898-458069A3-CBBC-4E1F-930D-1AAFEB35E393Q27679485-5266FAC1-0B18-4C15-AC8D-7F0AB1D2B274Q28533560-198FF425-E84D-4025-88ED-7B1E7434BF20Q28540502-12B30FC0-5A51-46F4-8D0F-429D7EFC4E6DQ28544898-9BA78E49-7FF4-4E13-B45A-037C83597D66Q30379387-BC19BD33-3470-40EA-82AC-94C89F60BD59Q30610715-EFB80E1B-45E6-4196-94C4-A288FCCD1AE0Q30660049-0560D84D-B9A4-4C25-841F-9F00AF4F2F6DQ31055925-B6DC54A2-BF97-4C13-B16C-367383B75230Q33654425-D44D526D-1BBC-4352-B939-C0E68951DB0EQ33761247-F4688546-298C-416E-A1BA-04F1D9C72F18Q33788913-2C8E75CA-EA32-41F3-93E4-E1B87B57ABBEQ33922305-17FB6A7A-69D8-4578-AEDC-ED6A76202048Q34211441-70CD65BE-C7CF-4D39-ADD8-334DC2B57261Q34414446-74CAC1E6-F2F1-4571-9394-65D223DAB608Q35048841-B2A6059A-099B-4BC4-849E-FF00696DE250Q35309786-AC69848D-360B-49B9-8E71-AC23C4EFE2AAQ36088674-5384E993-CA90-401E-AC3F-3B552F76154AQ36110838-B6811FBB-A969-4CA2-B5D8-3A002B79A1CAQ36198935-D72634AE-5129-49DC-B85C-596C0DA08DABQ36216005-931BB00B-141E-4EB4-ACCC-43BBBC7114BCQ36234699-900165EC-84D4-400E-9809-AF55C68412C8Q36277923-58E19800-5650-472D-A3C0-A2022F1CE45AQ36499643-4AC9A490-F559-4F39-ACE2-A23320D973B9Q36598899-626ED201-3343-4001-BC05-358320563A12Q36600026-07A26F4A-BD7C-44DD-AF40-3C530B6F8DB8Q36630032-45582CDF-1F4D-49B1-8735-2F828B969071Q36736308-D606F24E-950B-4389-93DD-08A1924719F0Q36936466-8422E034-3D7B-4513-9DD9-3A76DC5DDAE7Q37142133-61663AD9-AFB5-4957-B4C7-C0A99018ACF7Q37157361-0D9DCB86-CA44-4905-9CA4-ED6A3A68850DQ37475977-FB543545-8AEF-4AD6-8170-E7EB99D6CA8FQ37550841-EADDC0AA-B2E8-4DDF-90A5-6E3503280C11Q37596830-67842D0D-CE99-4741-8A25-62D6C76555F1Q37716781-0C9C73BA-918F-4171-A68B-875EA9D6D270Q37981477-E265FAAA-41E8-4FCD-9355-A27380FEEB61Q38124811-765B307D-0CB0-40D8-A7BC-6D4977A7B17EQ38160307-700C515A-164B-490C-B49D-613B8238930FQ38261844-CC2AE282-7D10-4A63-A5F7-0368E35DDE47
P2860
The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils.
@ast
The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils.
@en
type
label
The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils.
@ast
The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils.
@en
prefLabel
The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils.
@ast
The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils.
@en
P2093
P2860
P356
P1476
The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils.
@en
P2093
Cody L Hoop
Murali Jayaraman
Patrick C A van der Wel
Ravindra Kodali
Ronald Wetzel
V N Sivanandam
P2860
P304
P356
10.1021/JA110715F
P407
P577
2011-03-07T00:00:00Z